Find clinical trials for Endometrial Cancer in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Durham, NC, USA:
This is a a Simon's two-stage, non-randomized, open label, 2-arm Phase II trial of ONC201 in women with metastatic or recurrent Type II endometrial...
Phase 2
Chapel Hill, North Carolina, United States and 2 other locations
This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...
Phase 1, Phase 2
Durham, North Carolina, United States and 19 other locations
Endometrial cancer (EC) is the fourth most common cancer in United States women, and alarmingly, the frequency and mortali...
Phase 1
Chapel Hill, North Carolina, United States of America
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Chapel Hill, North Carolina, United States of America and 66 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Durham, North Carolina, United States and 162 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Durham, North Carolina, United States and 75 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Durham, North Carolina, United States and 168 other locations
antigen (HLA) and MAGE-A4 tumor antigen. Tumor indications include endometrial, esophageal, esophagogastric junction (EGJ), gastric, head an....
Phase 1
Durham, North Carolina, United States and 21 other locations
This study, ELU- FRα-1, is focused on adult subjects who have advanced, recurrent or refractory folate receptor alpha (FRα) overexpressing tumors con...
Phase 1, Phase 2
Durham, North Carolina, United States and 17 other locations
Phase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.
Phase 1
Chapel Hill, North Carolina, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal